187 related articles for article (PubMed ID: 31905229)
1. Ligand dependent gene regulation by transient ERα clustered enhancers.
Saravanan B; Soota D; Islam Z; Majumdar S; Mann R; Meel S; Farooq U; Walavalkar K; Gayen S; Singh AK; Hannenhalli S; Notani D
PLoS Genet; 2020 Jan; 16(1):e1008516. PubMed ID: 31905229
[TBL] [Abstract][Full Text] [Related]
2. Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells.
Miano V; Ferrero G; Rosti V; Manitta E; Elhasnaoui J; Basile G; De Bortoli M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462945
[TBL] [Abstract][Full Text] [Related]
3. Widespread enhancer activation via ERα mediates estrogen response in vivo during uterine development.
Jefferson WN; Kinyamu HK; Wang T; Miranda AX; Padilla-Banks E; Suen AA; Williams CJ
Nucleic Acids Res; 2018 Jun; 46(11):5487-5503. PubMed ID: 29648668
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.
Tong Z; Liu Y; Yu X; Martinez JD; Xu J
J Biol Chem; 2019 Dec; 294(51):19667-19682. PubMed ID: 31744881
[TBL] [Abstract][Full Text] [Related]
5. Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program.
Tan Y; Jin C; Ma W; Hu Y; Tanasa B; Oh S; Gamliel A; Ma Q; Yao L; Zhang J; Ohgi K; Liu W; Aggarwal AK; Rosenfeld MG
Mol Cell; 2018 Aug; 71(4):526-539.e8. PubMed ID: 30118678
[TBL] [Abstract][Full Text] [Related]
6. Establishment of active chromatin structure at enhancer elements by mixed-lineage leukemia 1 to initiate estrogen-dependent gene expression.
Jeong KW; Andreu-Vieyra C; You JS; Jones PA; Stallcup MR
Nucleic Acids Res; 2014 Feb; 42(4):2245-56. PubMed ID: 24288367
[TBL] [Abstract][Full Text] [Related]
7. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
8. Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching.
Murakami S; Nagari A; Kraus WL
Genes Dev; 2017 Aug; 31(15):1535-1548. PubMed ID: 28887413
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor α (ERα)-binding super-enhancers drive key mediators that control uterine estrogen responses in mice.
Hewitt SC; Grimm SA; Wu SP; DeMayo FJ; Korach KS
J Biol Chem; 2020 Jun; 295(25):8387-8400. PubMed ID: 32354741
[TBL] [Abstract][Full Text] [Related]
10. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional co-repressor TLE3 suppresses basal signaling on a subset of estrogen receptor α target genes.
Jangal M; Couture JP; Bianco S; Magnani L; Mohammed H; Gévry N
Nucleic Acids Res; 2014 Oct; 42(18):11339-48. PubMed ID: 25223786
[TBL] [Abstract][Full Text] [Related]
12. The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin.
Guo C; Meza-Sosa KF; Valle-Garcia D; Zhao G; Gao K; Yu L; Zhang H; Chen Y; Sun L; Rockowitz S; Wang S; Jiang S; Lieberman J
Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2206878120. PubMed ID: 36791099
[TBL] [Abstract][Full Text] [Related]
13. Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells.
Won Jeong K; Chodankar R; Purcell DJ; Bittencourt D; Stallcup MR
Mol Endocrinol; 2012 Jun; 26(6):955-66. PubMed ID: 22543272
[TBL] [Abstract][Full Text] [Related]
14. The RUNX Transcriptional Coregulator, CBFβ, Suppresses Migration of ER
Pegg HJ; Harrison H; Rogerson C; Shore P
Mol Cancer Res; 2019 May; 17(5):1015-1023. PubMed ID: 30655324
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
Madak-Erdogan Z; Katzenellenbogen BS
Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
[TBL] [Abstract][Full Text] [Related]
16. Classification of different types of estrogen receptor alpha binding sites in MCF-7 cells.
Bojcsuk D; Bálint BL
J Biotechnol; 2019 Jun; 299():13-20. PubMed ID: 31039369
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.
Caizzi L; Ferrero G; Cutrupi S; Cordero F; Ballaré C; Miano V; Reineri S; Ricci L; Friard O; Testori A; Corà D; Caselle M; Di Croce L; De Bortoli M
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4892-7. PubMed ID: 24639548
[TBL] [Abstract][Full Text] [Related]
18. Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.
Murakami S; Li R; Nagari A; Chae M; Camacho CV; Kraus WL
Mol Cancer Res; 2019 Dec; 17(12):2356-2368. PubMed ID: 31551256
[TBL] [Abstract][Full Text] [Related]
19. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.
Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z
Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470
[TBL] [Abstract][Full Text] [Related]
20. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
